SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE.
ATRX 0.00010000.0%Aug 1 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: software salesperson who wrote (68)3/3/1999 11:53:00 PM
From: gcrispin  Read Replies (2) of 182
 
I think the research shows that, with Atridox, margin gain was best in the deepest pockets. This is something to check with the company.

Also, in deeper pockets there is no guarantee that SRP will be effective. In reality, the deeper the pocket, the less chance for all the calculus to be removed. My brother is a dentist and he has told me of instances where SRP results in closing the pocket halfway down, thereby creating an abscess below the pocket closure.

I really don't see how this dentist could call Atridox expensive. The conference call stated that a unit costs roughly forty to forty-five dollars, and it will treat one quadrant, or one-fourth of the mouth. Dentists are using that one unit and charging one hundred to one hundred twenty dollars. The procedure is a ten to fifteen minute affair, so they are making a lot of money in terms of chair time.

Just my thoughts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext